Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Edmonton, Calgary, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Edmonton, Calgary, Spokane WA, Missoula MT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase 3, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase 3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase 3, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Edmonton, Calgary, Spokane WA, Seattle WA, Renton WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase 3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase 3, Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for
Atrial Fibrillation, Stroke, Bleeding
Location: Edmonton, Salt Lake City UT, Murray UT, Rochester MN,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04045665

Phase 3, Recruiting

The STOP-MED CTRCD Trial

for
Heart Failure, Cardiotoxicity, Cardiac Toxicity,
Location: Edmonton, Winnipeg, Toronto, Ottawa, Boston MA
Sponsor: Dinesh Thavendiranathan

Sex: All

Age: 18+

Code: NCT06183437

Recruiting

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: Edmonton, Calgary, Seattle WA, Rochester MN,
Sponsor: Population Health Research Institute

Sex: All

Age: 18+

Code: NCT04774159

Phase 3, Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

for
Heart Diseases, Coronary Artery Disease,
Location: Edmonton, New Westminster, Winnipeg, Salt Lake City UT,
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18+

Code: NCT04124120

Recruiting

Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

for
Left Bundle-Branch Block, Aortic Valve Stenosis
Location: Edmonton, London, Hamilton, Ottawa, Montreal,
Sponsor: Montreal Heart Institute

Sex: All

Age: 18+

Code: NCT03303612

Recruiting

Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

for
Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Location: Edmonton, Rochester MN, San Francisco CA, Iowa City IA,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18 - 70+

Code: NCT03536312

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Edmonton, Kelowna, Spokane WA, Surrey, Vancouver,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase 3, Recruiting

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

for
ACS (Acute Coronary Syndrome), Hyperlipidemia, Dyslipidemia,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT07685639

Recruiting

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Edmonton, Victoria, Rapid City SD, Clinton UT,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase 2, Recruiting

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

for
Type 2 Diabetes, Obesity, Semaglutide, GLP-1, Diabetes
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 70+

Code: NCT07272837

Recruiting